EDIT vs KR
Editas Medicine Inc (EDIT) versus Kroger Company (KR) — a side-by-side from cached financials, not a winner call.
Editas Medicine Inc (EDIT) is a biotechnology company listed on NASDAQ.
Kroger Company (KR) is a grocery stores company listed on US.
Latest reported EDIT revenue for 2024-12-31 was $32.3M. Net income was -$237.1M. Revenue was down 58.6% from 2023-12-31 to 2024-12-31. EDIT currently screens at market cap $375.2M.
Latest reported KR revenue for 2025-02-01 was $147.12B. Net income was $2.67B. KR currently screens at market cap $46.17B and trailing P/E 19.0.
EDIT currently screens at market cap $375.2M. KR currently screens at market cap $46.17B and trailing P/E 19.0.
Not investment advice. Open the EDIT and KR stock pages for the full models.
Not investment advice.